Table 3.
Probability of not prescribing a disease-modifying anti-rheumatic drug
|
Univariate, OR (95% CI) |
Multivariatea, OR (95% CI) |
|
|---|---|---|
| Years practicing medicine | ||
| 0-1 | 5.07 (0.69-37) | 1.44 (0.14-14.83) |
| 2-10 | 1.30 (0.68-2.49) | 0.98 (0.48-2.01) |
| 11+ | 1 | 1 |
| RA patients seen in last year | ||
| 0-5 | 2.46 (1.30-4.67) | 1.74 (0.85-3.58) |
| 6+ | 1 | 1 |
| Confidence in ability to diagnose RA | ||
| Very of somewhat confident | 1 | 1 |
| Less than or no confidence | 3.53 (1.41-8.82) | 2.07 (0.72-5.95) |
| Additional RA education beyond medical school | ||
| Yes | 1 | 1 |
| No | 1.46 (0.79-2.73) | 0.92 (0.45-1.89) |
| Proportion of RA patients who are good candidates for DMARDs | ||
| 0%-50% | 2.88 (1.22-6.82) | 2.41 (0.96-6.08) |
| 51%-75% | 1.01 (0.39-2.59) | 0.85 (0.31-2.32) |
| 76%-100% | 1 | 1 |
| Physicians' knowledge level of DMARDs | ||
| Very knowledgeable | 1 | 1 |
| Somewhat knowledgeable | 2.13 (0.27-16) | 1.22 (0.15-10.2) |
| Lacking sufficient or any knowledge | 9.87 (1.23-79) | 5.20 (0.60-44) |
aMultivariate model included all variables shown in the table. CI, confidence interval; DMARD, disease-modifying anti-rheumatic drug; OR, odds ratio; RA, rheumatoid arthritis.